Safe Oral Triiodo-L-Thyronine Therapy Protects from Post-Infarct Cardiac Dysfunction and Arrhythmias without Cardiovascular Adverse Effects

BACKGROUND: A large body of evidence suggests that thyroid hormones (THs) are beneficial for the treatment of cardiovascular disorders. We have shown that 3 days of triiodo-L-thyronine (T3) treatment in myocardial infarction (MI) rats increased left ventricular (LV) contractility and decreased myocy...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajagopalan, Viswanathan, Zhang, Youhua, Ojamaa, Kaie, Chen, Yue-feng, Pingitore, Alessandro, Pol, Christine J., Saunders, Debra, Balasubramanian, Krithika, Towner, Rheal A., Gerdes, A. Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794221/
https://www.ncbi.nlm.nih.gov/pubmed/26981865
http://dx.doi.org/10.1371/journal.pone.0151413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794221/
https://www.ncbi.nlm.nih.gov/pubmed/26981865
http://dx.doi.org/10.1371/journal.pone.0151413

Ejemplares similares